Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study (Q24645666)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study	scientific article

Statements

scholarly article

0 references

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study (English)

0 references

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

S Ohwada

1

0 references

T Ikeya

2

0 references

T Yokomori

3

0 references

T Kusaba

4

0 references

T Roppongi

5

0 references

T Takahashi

6

0 references

S Nakamura

7

0 references

S Kakinuma

8

0 references

S Iwazaki

9

0 references

H Ishikawa

10

0 references

S Kawate

11

0 references

T Nakajima

12

0 references

Y Morishita

13

0 references

language of work or name

0 references

publication date

8 March 2004

0 references

British Journal of Cancer

0 references

90

0 references

5

0 references

1003-10

0 references

Trends in long-term survival following liver resection for hepatic colorectal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Mesorectal excision for rectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Phase II trial of UFT in advanced colorectal and gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: enhancement of the activity by a polysaccharide preparation, krestin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

27 September 2017

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

30 May 2018

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

30 May 2018

Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

30 May 2018

Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

30 May 2018

Adjuvant chemotherapy in the surgical treatment of large bowel cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

30 May 2018

Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

19 June 2018

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601619

21 January 2018

Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601619

21 January 2018

Micrometastases and survival in stage II colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601619

21 January 2018

An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601619

21 January 2018

Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601619

21 January 2018

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

28 November 2018

Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

28 November 2018

Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409633

28 November 2018

Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant Chemotherapy in Cancer of the Colon and Rectum: Demonstration of Effectiveness of Prolonged 5-FU Chemotherapy in a Prospectively Controlled, Randomized Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/14997197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6601619

0 references

Dimensions Publication ID

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24645666&oldid=2175257239"